Form D · Other Technology
Pario Health Inc.
New York, NY · CIK 0002041479
Offering snapshot reported Oct 21, 2024 · SEC filing
- Reported sold
- $4M Offering amount: $4M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 7, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 21, 2024 | Initial | $4,000,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-527316
The Total Offering Amount and Total Amount Sold includes the conversion of $1,850,000 in outstanding convertible securities.
Source: Form D, filed Oct 21, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joshua Baiad | Director, Executive, Promoter |
| Mary Margaret Diehl | Director, Executive, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
14 Wall Street, Suite 2080
New York, NY, 10005
New York, NY, 10005